Agenda
Transforming the earlier detection of oesophageal cancer
25 May 2023
| 09.30 | Registration and coffee |
| 10.00 | Welcome Marcel Gehrung |
| >> | All you need to know about the technology and diagnostic pathways |
| 10.10 | Recap of evidence base Rebecca Fitzgerald |
| 10.35 | All you need to know about the pathology Maria O’Donovan |
| 10.50 | Diagnostic pathways – use in Reflux and Barrett’s patient management Danielle Morris |
| 11.10 | Coffee |
| >> | The impact from real-world implementation |
| 11.45 | The NHS Scotland programme: Impact so far, data & next steps Paul Glen |
| 12.05 | The NHS England programme: Impact so far, data & next steps Rory Harvey |
| 12.25 | How to use Cytosponge to recover & prioritise endoscopy waiting lists Danielle Morris (chair), Rehan Haidry, Charlie Gordon, Arin Saha, Craig Vickery |
| 12.55 | Lunch |
| >> | On pathway transformation and service improvement |
| 13.45 | How to transform referral pathways for reflux Rebecca Fitzgerald (chair), Danielle Morris, Peter Holloway |
| 14.10 |
How to develop & support a nurse-led service |
| 14.40 | Coffee |
| >> | What is next for Cytosponge? |
| 15.05 | Community based clinics with the CYTOPRIME projects Charlene Tang (chair) Amanda Short, Mike Kenny, Graeme Redshaw |
| 15.35 | National guidelines and the BEST4 trial Massi di Pietro |
| 15.50 | Closing speech Marcel Gehrung |
| 16.00 | Close |
Supported by:
